Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:56:19 EDT Sat 20 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:CYCC
- CYCLACEL PHARMACEUTICALS INC -
http://www.cyclacel.com
08:56:19 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
CYCC
- Q
1.5
1.70
·
2.89
1.2
1.78
-0.08
-4.3
10.3
18
52
1.89
1.95
1.7717
13.1934 1.52
19:49:34
Apr 01
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Financial Status:
Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 52
More trades...
Time ET
Ex
Price
Change
Volume
19:49:34
Q
1.75
-0.10
15
19:49:34
Q
1.75
-0.10
50
16:00:01
Q
1.79
-0.06
14
16:00:01
Q
1.79
-0.06
3
16:00:01
Q
1.79
-0.06
1
15:59:53
Q
1.78
-0.08
100
15:59:53
Q
1.78
-0.07
23
15:59:52
Q
1.79
-0.06
28
15:58:14
Q
1.80
-0.05
20
15:19:19
Q
1.8079
-0.0421
11
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-01 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer
2024-03-19 16:05
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2024-03-13 16:05
U:CYCC
News Release
200
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
2024-03-07 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
2024-03-06 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
2024-02-20 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference
2024-01-30 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
2024-01-08 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
2024-01-02 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024
2023-12-22 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
2023-12-18 09:00
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions
2023-12-12 16:05
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Announces Reverse Stock Split
2023-11-30 09:15
U:CYCC
News Release
200
Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC
2023-11-28 17:15
U:CYCC
News Release
200
Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q
2023-11-13 16:05
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
2023-11-07 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results
2023-08-09 16:05
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
2023-08-03 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results
2023-05-11 16:05
U:CYCC
News Release
200
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
2023-05-04 09:15
U:CYCC
News Release
200
Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial Results